aldoxorubicin
Showing 1 - 20 of 20
Metastatic Solid Tumors Trial in Scottsdale, Santa Monica (aldoxorubicin, gemcitabine)
Completed
- Metastatic Solid Tumors
- aldoxorubicin
- gemcitabine
-
Scottsdale, Arizona
- +1 more
Jan 27, 2022
Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma Trial in Santa Monica (aldoxorubicin, ifosfamide)
Completed
- Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma
- aldoxorubicin
- ifosfamide
-
Santa Monica, CaliforniaSarcoma Oncology Center
Jan 27, 2022
Kaposi's Sarcoma, HIV Positive, AIDS Trial in New Orleans (aldoxorubicin)
Completed
- Kaposi's Sarcoma
- +2 more
- aldoxorubicin
-
New Orleans, LouisianaLouisiana State University Health Science Center
Jan 27, 2022
Advanced Solid Tumors Trial in Los Angeles (aldoxorubicin)
Completed
- Advanced Solid Tumors
- aldoxorubicin
-
Los Angeles, CaliforniaSamuel Oschin Comprehensive Cancer Institute
Jan 27, 2022
Advanced Solid Tumor Trial in Santa Monica (aldoxorubicin)
Completed
- Advanced Solid Tumor
- aldoxorubicin
-
Santa Monica, CaliforniaSarcoma Oncology Center
Jan 27, 2022
Glioblastoma Trial in United States (aldoxorubicin)
Completed
- Glioblastoma
- aldoxorubicin
-
Duarte, California
- +3 more
Jan 27, 2022
Triple Negative Breast Cancer (TNBC) Trial in El Segundo (Leucovorin, 5-Fluorouracil, Aldoxorubicin HCl)
Withdrawn
- Triple Negative Breast Cancer (TNBC)
- Leucovorin
- +15 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Mar 28, 2022
Colorectal Cancer Metastatic, mCRC Trial in El Segundo (biological, drug, procedure)
Active, not recruiting
- Colorectal Cancer Metastatic
- mCRC
- Aldoxorubicin Hydrochloride
- +19 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Mar 28, 2022
Non Small Cell Lung Cancer Trial in El Segundo (Nab-paclitaxel, Cisplatin, 5Fluorouracil)
Withdrawn
- Non Small Cell Lung Cancer
- Nab-paclitaxel
- +14 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Mar 28, 2022
Triple Negative Breast Cancer Trial in El Segundo (drug, biological, procedure)
Active, not recruiting
- Triple Negative Breast Cancer
- Aldoxorubicin HCl
- +17 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Mar 28, 2022
Chordoma, Unresectable Malignant Tumor Trial in El Segundo (biological, drug, radiation)
Withdrawn
- Chordoma
- Unresectable Malignant Neoplasm
- Aldoxorubicin Hydrochloride
- +9 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Mar 17, 2021
Metastatic Pancreatic Cancer Trial in El Segundo (Gemcitabine, Nab-paclitaxel, Aldoxorubicin HCl)
Withdrawn
- Metastatic Pancreatic Cancer
- Gemcitabine
- +18 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Mar 17, 2021
Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma Trial in Worldwide (Aldoxorubicin, Investigator's Choice
Completed
- Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma
- Aldoxorubicin
- Investigator's Choice Treatment (Darcabazine, Pazopanib, Gemcitabine + Docetaxel, Doxorubicin, Ifosfamide)
-
Birmingham, Alabama
- +73 more
Mar 28, 2022
Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent Trial in El Segundo (biological, drug, procedure)
Withdrawn
- Hepatocellular Carcinoma Non-resectable
- Hepatocellular Carcinoma Recurrent
- ETBX-011
- +17 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Mar 17, 2021
Squamous Cell Carcinoma Trial in El Segundo (drug, biological, procedure)
Unknown status
- Squamous Cell Carcinoma
- Aldoxorubicin HCl
- +20 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Aug 10, 2020
Pancreatic Cancer Trial in El Segundo (drug, biological, procedure)
Unknown status
- Pancreatic Cancer
- Aldoxorubicin HCl
- +18 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Jul 14, 2019
Pancreatic Cancer Trial in El Segundo (drug, biological, procedure)
Unknown status
- Pancreatic Cancer
- Aldoxorubicin HCl
- +14 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Jul 14, 2019
Sarcoma, Soft Tissue Trial in Shenyang (anlotinib)
Unknown status
- Sarcoma, Soft Tissue
-
Shenyang, Liaoning, ChinaLiaoning Province Tumor Hospital
Jul 7, 2019
Metastatic Small Cell Lung Cancer Trial in Hungary, Spain, United States (Aldoxorubicin, Topotecan)
Unknown status
- Metastatic Small Cell Lung Cancer
- Aldoxorubicin
- Topotecan
-
Los Angeles, California
- +36 more
Aug 17, 2016
Sarcoma Trial in Philadelphia (aldoxorubicin)
No longer available
- Sarcoma
- aldoxorubicin
-
Philadelphia, PennsylvaniaThomas Jefferson University
Oct 21, 2015